India has launched its first-in-human gene therapy trial for Haemophilia, led by BRIC-inStem and CMC Vellore. Union Minister Dr. Jitendra Singh reviewed the program at BRIC-inStem, Bengaluru. He stressed that biotechnology is key to India’s healthcare and economic future.

BulletsIn

• India’s first gene therapy trial for Haemophilia underway
• Led by BRIC-inStem with CMC Vellore; reviewed in Bengaluru
• Minister calls it major scientific and national milestone
• Biotech seen as pillar of economy and healthcare reform
• India’s biotech sector now worth $165.7 billion; 16× growth in 10 yrs
• Target: $300 billion biotech sector by 2030
• Over 10,000 biotech startups; just 50 a decade ago
• BRIC’s innovations: antiviral mask, Kisan Kavach for farmers
• New facilities: Biosafety Lab, CReATE Centre for neonatal care
• Minister urges MD-PhD programs, better research visibility